Skip to main content
. Author manuscript; available in PMC: 2016 Aug 2.
Published in final edited form as: Lancet Oncol. 2012 Jun 14;13(7):734–742. doi: 10.1016/S1470-2045(12)70226-7

Figure 3. Disease-free and overall survival.

Figure 3

1656 patients in the placebo group and 1655 in the clodronate group. 312 events arose with placebo and 286 with clodronate. 167 patients died in the placebo group and 140 in the clodronate group.